# Neurotrophin Expression in Infants as a Predictor of Respiratory and Neurodevelopmental Outcomes

> **NCT03373539** · — · COMPLETED · sponsor: **The Cleveland Clinic** · enrollment: 70 (actual)

## Conditions studied

- Bronchopulmonary Dysplasia
- Chronic Lung Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03373539
- **Lead sponsor:** The Cleveland Clinic
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12
- **Primary completion:** 2019-08
- **Final completion:** 2019-08
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2025-11-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03373539

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03373539, "Neurotrophin Expression in Infants as a Predictor of Respiratory and Neurodevelopmental Outcomes". Retrieved via AI Analytics 2026-09-23 from https://api.ai-analytics.org/clinical/NCT03373539. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*